Commentaryon'Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: A double-blind, randomised controlled trial'

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 119, Issue 8, 2012, Pages 982-983

  Weeks, A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PLACEBO;

BLEEDING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG MEGADOSE; EFFECT SIZE; FEMALE; HUMAN; MAXIMUM PLASMA CONCENTRATION; NOTE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; TABLET;

EID: 84862570838     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03341.x     Document Type: Note

References (0)